Propranolol: Clinical Trials

126 trials of Propranolol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

47 completed, 23 terminated, 20 unknown, 16 recruiting. 126 Phase 2, 21 Phase 3, 11 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2126Completed 47, Terminated 23, Unknown 20, Recruiting 16, Withdrawn 8, Active not recruiting 4, Not yet recruiting 4, Suspended 4
Phase 321Completed 9, Terminated 5, Unknown 4, Withdrawn 2, Recruiting 1
Phase 111Suspended 2, Terminated 2, Unknown 2, Active not recruiting 1, Completed 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow Propranolol: new trials by email Literature Review of Propranolol trials Research Report on Propranolol

Trials (filtered) newest first · largest first

All 126 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer
Biospecimen Collection, Cholecalciferol, Computed Tomography - Advanced Hepatocellular Carcinoma, Advanced Melanoma
Phase 2Not yet recruitingUniversity of Southern California462026-11-012026-09-23
Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence
Propranolol, 120mg, Placebo - PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingUniversity Hospital, Tours342026-09-012026-03-05
A Study of Propranolol to Treat Kaposi Sarcoma
Propranolol - Kaposi Sarcoma
Phase 2RecruitingAIDS Malignancy Consortium252026-08-312026-10-05
Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ Adenocarcinoma
propranolol, Toripalimab, Oxaliplatin - Gastric or Gastroesophageal Junction Adenocarcinoma, Propranolol
Phase 1 / Phase 2Not yet recruitingTing Liu492026-08-012026-07-27
Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study
Iparomlimab/Tuvonralimab, Capecitabine, Oxaliplatin - Colon Cancer (Stage II &Amp; III), Immunotherapy
Phase 2Not yet recruitingSun Yat-sen University452026-04-202026-04-24
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
Propranolol, Placebo - Autism Spectrum Disorder, Challenging Behaviour
Phase 2RecruitingJeremy Veenstra-vanderweele602026-01-302026-09-01
Propranolol Treatment for Postoperative Chylothorax
Propranolol Hydrochloride, Placebo - Postoperative Chylothorax, Congenital Heart Disease
Phase 1 / Phase 2SuspendedJune Wu502025-09-092026-05-15
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Propranolol Hydrochloride - Kaposi Sarcoma
Phase 2RecruitingWashington University School of Medicine252025-08-202026-04-06
Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer
Propranolol Hydrochloride, Paclitaxel liposome, Carboplatin - Ovarian Cancer
Phase 2RecruitingBai-Rong Xia1362025-06-202026-06-30
Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression
Propranolol (Beta-Blocker) and Etodolac (COX-2 Inhibitor), Placebo (Matching for Propranolol & Etodolac) - Ovarian Cancer, Ovarian Cancer Metastatic Recurrent
Phase 2RecruitingTel-Aviv Sourasky Medical Center602025-03-122025-07-11
Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain Injury
control, propranolol, Carvedilol - TBI Traumatic Brain Injury
Phase 1 / Phase 2RecruitingMansoura University1002025-01-202025-04-02
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
propranolol - Infantile Hemangioma
Phase 2 / Phase 3RecruitingWest China Hospital322025-01-012026-11-12
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
propranolol (beta-blocker used treat high blood pressure) - Gastrointestinal Tumors
Phase 2RecruitingHuashan Hospital402024-12-012025-01-14
Efficacy of Traumatic Memory Modification Using Memory Reconsolidation and Propranolol Among Adolescents With PTSD
Propranolol, Placebo - Post Traumatic Stress Disorder
Phase 2WithdrawnRennes University Hospital2024-10-012025-09-08
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Biopsy, Biospecimen Collection, Computed Tomography - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Phase 2RecruitingEmory University372024-09-012026-06-04
Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC.
Propranolol, Placebo - Pancreatic Cancer, Surgery
Phase 2RecruitingZealand University Hospital302024-03-202024-03-28
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Amivantamab IV, Amivantamab SC, Lazertinib - Carcinoma, Non-Small-Cell Lung
Phase 2Active not recruitingJanssen Research & Development, LLC3052024-02-162026-11-03
Testing a Novel Therapeutic Strategy for Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder
Propranolol, Placebo - Stress Disorders, Post-Traumatic, Alcohol Use Disorder
Phase 2CompletedCentre for Addiction and Mental Health482023-07-152026-06-15
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
Durvalumab, Gemcitabine, Nab paclitaxel - Pancreatic Cancer, Hepatocellular Cancer
Phase 2Active not recruitingAHS Cancer Control Alberta152023-07-052026-11-04
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
Biopsy, Biospecimen Collection, Computed Tomography - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8
Phase 2RecruitingRoswell Park Cancer Institute402023-03-072025-12-16

Showing 20 of 126. Sign in to see all of them.

Conditions studied

Stress Disorders, Post-Traumatic (13)  ·  Burns (6)  ·  Melanoma (5)  ·  Retinopathy of Prematurity (5)  ·  Brain Injuries, Traumatic (4)  ·  Cocaine-Related Disorders (4)  ·  Wounds and Injuries (4)  ·  Adjustment Disorders (3)  ·  Behavior, Addictive (3)  ·  Hemangioma (3)  ·  Hemangiosarcoma (3)  ·  Hypertension, Portal (3)  ·  Pancreatic Neoplasms (3)  ·  Prostatic Neoplasms (3)  ·  Stress Disorders, Traumatic, Acute (3)

Sponsors

Douglas Mental Health University Institute (5)  ·  The University of Texas Medical Branch, Galveston (5)  ·  Emory University (3)  ·  Medical University of South Carolina (3)  ·  Roswell Park Cancer Institute (3)  ·  University of North Carolina, Chapel Hill (3)  ·  Assaf-Harofeh Medical Center (2)  ·  Columbia University (2)  ·  Johns Hopkins University (2)  ·  Meyer Children's Hospital IRCCS (2)  ·  National Institute of Mental Health (NIMH) (2)  ·  University Hospital, Toulouse (2)  ·  University of Dundee (2)  ·  Vicus Therapeutics (2)  ·  AHS Cancer Control Alberta (1)

Countries

United States (56)  ·  Canada (14)  ·  China (8)  ·  France (8)  ·  Germany (5)  ·  Brazil (4)  ·  Israel (4)  ·  Italy (4)  ·  Norway (4)  ·  Egypt (3)  ·  Switzerland (3)  ·  Taiwan (3)  ·  Argentina (2)  ·  Denmark (2)  ·  Mexico (2)

Top investigators

David N Herndon, MD (4)  ·  Alain Brunet, Ph.D. (2)  ·  Brian J Lipworth, MD (2)  ·  Oded Zmora, MD (2)  ·  Ahmed Hassan, MD (1)  ·  Ahmed T Ahmed, A professor (1)  ·  Alain Brunet, PhD. (1)  ·  Ana K Tamara, Physician (1)  ·  Anna Blecher, Dr. (1)  ·  Anu Sharma, MD (1)  ·  Anurag Singh, MD (1)  ·  Ashok Hemal (1)  ·  Bai-Rong Xia, Doctor (1)  ·  Barbie Zimmerman-Bier, M.D. (1)

Results publications

PMID 22606232, PMID 42088573, PMID 15583741, PMID 15890495, PMID 15911704, PMID 15978266, PMID 16697124, PMID 18791359, PMID 19240154, PMID 19687359, PMID 19734776, PMID 20395554, PMID 20701787, PMID 20739853, PMID 20881067, PMID 21789167, PMID 22365565, PMID 22463890, PMID 22895351, PMID 23013802, PMID 23150682, PMID 23303450, PMID 23321647, PMID 23511841, PMID 23593932, PMID 24002370, PMID 24009246, PMID 24054431, PMID 24227635, PMID 24298851, PMID 24335848, PMID 24347141, PMID 24495468, PMID 24526257, PMID 24606242, PMID 24655871, PMID 24721800, PMID 24824900, PMID 24918945, PMID 24938324, PMID 25211297, PMID 25514427, PMID 25693013, PMID 25807408, PMID 25968340, PMID 26123421, PMID 26607848, PMID 27171844, PMID 27433905, PMID 28065396

NIH funding

2008 (2), 2017 (2), 2023 (2), P50GM060338 (2), 1RC1AA019019-01 (1), 2015 (1), K01HL096434 (1), K08CA279766 (1), K20DA000238 (1), P30CA012197 (1), P30CA014089 (1), P30CA138292 (1), P50DA012756 (1), R01AA022285 (1), R01GM056687 (1)